The Latest in Alzheimer's & Cognition

Clinical Psychiatry News

Full report confirms solanezumab’s failure to rescue cognition in mild Alzheimer’s

January 25, 2018

Clinical Psychiatry News

Idalopirdine falls short in three phase 3 Alzheimer’s trials

January 9, 2018

Clinical Psychiatry News

Cars that recognize hypoglycemia? Maybe soon

January 3, 2018

Clinical Psychiatry News

Tau imaging predicts looming cognitive decline in cognitively normal elderly

December 26, 2017

Clinical Psychiatry News

Head injury linked to amyloid deposition decades later

December 19, 2017

Clinical Psychiatry News

Up to 47 million Americans may have “preclinical” Alzheimer’s disease, study estimates

December 13, 2017

Clinical Psychiatry News

Retinal changes may reflect brain changes in preclinical Alzheimer’s

December 4, 2017

Clinical Psychiatry News

Walking has beneficial cognitive effects in amyloid-positive older adults

December 3, 2017

Clinical Psychiatry News

Intepirdine flops in phase 3 study of mild to moderate Alzheimer’s patients

November 28, 2017

Clinical Psychiatry News

Development of a sigma 1 receptor agonist for Alzheimer’s proceeds based on 2-year phase 2 data

November 21, 2017

Clinical Psychiatry News

Long-term cholinesterase inhibition may slow cognitive decline – and more

November 15, 2017

Clinical Psychiatry News

Pimavanserin found modestly effective in phase 2 Alzheimer’s psychosis study

November 14, 2017

Clinical Psychiatry News

Amyloid imaging changed management for 80% of patients with uncertain dementia diagnosis

November 9, 2017

Clinical Psychiatry News

New BACE1 study launches in the shadow of verubecestat’s demise

November 4, 2017

Clinical Psychiatry News

Aducanumab continues to rack up positive numbers in phase 1b open-label extension

November 3, 2017